Biocon Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting
11-11-2025 | 08:34 pm
11-11-2025 | 08:34 pm
Biocon's board met, approving Q2/H1 financial results. Key decisions include early redemption of Rs. 500 Cr NCDs, acquiring Rs. 300 Cr in BBL CCDs to boost its stake (~65 bps), and planning to issue Commercial Papers up to Rs. 550 Cr.
No comments yet. Be the first to comment!
